AIDS Alert Archives – February 1, 2008
February 1, 2008
View Issues
-
CDC renews plan to reduce new HIV infections, but with more modest goals
The national five-year HIV strategic prevention plan, launched in 2001, was a failure. Everyone agrees with this assessment, including the agency that created it: the Centers for Disease Control and Prevention (CDC) of Atlanta, GA. -
Prevention experts discuss what might work to reduce HIV incidence
In the extended HIV prevention plan by the Centers for Disease Control and Prevention (CDC) in Atlanta, GA, there is renewed focus on expanding HIV testing and focusing on African Americans and the men who have sex with men (MSM) communities. -
Goals/Objectives of the CDC HIV Prevention Plan
Short-term Milestone 1: By 2010, decrease by at least 10 percent the number of persons in the United States at high risk for acquiring or transmitting HIV infection by delivering targeted, sustained and evidence-based HIV prevention interventions. -
Online film successful in reducing certain HIV risk behaviors
Internet-browsing men who have sex with men (MSM) apparently will respond to a dramatic, online short film with a message about reducing sexual risk behaviors, new research shows. -
New Jersey governor OKs law requiring HIV screening
New Jersey Gov. Richard Codey has signed legislation requiring healthcare providers to test pregnant women for HIV as part of routine prenatal care. The bill also requires testing of newborns whose mother's HIV status is either positive or unknown at the time of delivery. -
Global HIV vaccine trials face ethical challenges
HIV vaccine trials likely will continue for a decade or longer, raising questions about ethical considerations of enrolling participants across the globe. -
FDA Notifications
On Dec. 20, 2007, the FDA granted tentative approval for a generic formulation of efavirenz tablets, 600 mg, manufactured by Emcure Pharmaceuticals of Pune, India The application was reviewed under the expedited review provisions of the President's Emergency Plan for AIDS Relief (PEPFAR).